Dialogue Health Technologies - DLHTF Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$3.79
+0 (0.00%)

This chart shows the closing price for DLHTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Dialogue Health Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DLHTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DLHTF

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Dialogue Health Technologies in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$3.79.

This chart shows the closing price for DLHTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Dialogue Health Technologies. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/21/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/19/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/17/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/16/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/15/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/14/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
6/13/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/27/2023DesjardinsDowngradeBuy
7/27/2023CIBCDowngradeNeutral
7/27/2023TD SecuritiesDowngradeHold
3/23/2023CIBCBoost TargetC$3.50 ➝ C$4.00
3/23/2023TD SecuritiesBoost TargetC$3.25 ➝ C$4.00
12/29/2022National Bank FinancialLower Target$6.75 ➝ $6.25
11/16/2022DesjardinsLower Target$7.50 ➝ $5.00
11/16/2022Canaccord Genuity GroupLower Target$6.00 ➝ $5.00
11/16/2022National Bank FinancialLower Target$8.50 ➝ $6.75
11/16/2022ScotiabankLower Target$8.00 ➝ $5.50
9/23/2022Royal Bank of CanadaLower Target$6.00 ➝ $5.00
9/21/2022Canaccord Genuity GroupLower TargetBuy ➝ Buy$8.00 ➝ $6.00
9/21/2022TD SecuritiesLower Target$4.50 ➝ $3.50
8/15/2022Royal Bank of CanadaLower Target$7.00 ➝ $6.00
8/12/2022ScotiabankLower Target$8.50 ➝ $8.00
8/12/2022TD SecuritiesLower Target$5.50 ➝ $4.50
8/9/2022National Bank FinancialLower Target$11.50 ➝ $8.50
(Data available from 6/13/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/16/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/16/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/15/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/15/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/14/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Dialogue Health Technologies logo
Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
Read More

Today's Range

Now: C$3.79
Low: C$3.79
High: C$3.79

50 Day Range

MA: C$3.79
Low: C$3.79
High: C$3.79

52 Week Range

Now: C$3.79
Low: C$2.43
High: C$3.79

Volume

N/A

Average Volume

250 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Dialogue Health Technologies?

The following Wall Street sell-side analysts have issued stock ratings on Dialogue Health Technologies in the last year: CIBC, Desjardins, and TD Securities.
View the latest analyst ratings for DLHTF.

What is the current price target for Dialogue Health Technologies?

0 Wall Street analysts have set twelve-month price targets for Dialogue Health Technologies in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Dialogue Health Technologies in the next year.
View the latest price targets for DLHTF.

What is the current consensus analyst rating for Dialogue Health Technologies?

Dialogue Health Technologies currently has 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DLHTF, but not buy more shares or sell existing shares.
View the latest ratings for DLHTF.

What other companies compete with Dialogue Health Technologies?